PharmaMar: Pushing the borders
PharmaMar is driving the expansion of its US operations. To this end, the company has appointed Pascal Besman to the newly created role of Chief Operation Officer of the marine-derived oncology drug developers US subsidiary, PharmaMar US.
Besman joins PharmaMar from Maxim Group, a New York-based global investment bank, where he served as Head of Healthcare Equity Sales since 2014. Before Maxim Group, Besman served as a healthcare specialist and institutional equity salesperson at several investment banks, including JMP Securities, UBS, Bear Stearns, Lehman Brothers and Merrill Lynch.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium